about
Mesenchymal Stromal Cell Therapy in Ischemia/Reperfusion InjuryIntracranial pressure during liver transplantation for fulminant hepatic failure.Thiamine status in humans and content of phosphorylated thiamine derivatives in biopsies and cultured cells18-Fluoro-deoxyglucose uptake in inflammatory hepatic adenoma: A case reportCarcinoid tumor of the appendix: a consecutive series from 1237 appendectomiesCadaveric liver transplantation for non-acetaminophen fulminant hepatic failure: a 20-year experience.Strictureplasty in Crohn's disease: short- and long-term follow-up.Organ procurement after euthanasia: Belgian experience.Liver transplantation for acute hepatic failure due to chemotherapy-induced HBV reactivation in lymphoma patientsThe role of intraoperative cholangiography in detecting and preventing bile duct injury during laparoscopic cholecystectomy.Liver resection for noncolorectal, nonneuroendocrine metastases.First steps of laparoscopic surgery in Lubumbashi: problems encountered and preliminary resultsLiver Transplantation for Hepatic Trauma: A Study From the European Liver Transplant Registry.Risk of upper gastrointestinal cancer after bariatric operations.Preservation of cortical microcirculation after kidney ischemia-reperfusion: value of an iron chelator.Mesenchymal Stem Cells in Solid Organ Transplantation (MiSOT) Fourth Meeting: lessons learned from first clinical trials.A retrospective monocenter review of simultaneous pancreas-kidney transplantation.Contribution of donors after cardiac death to the deceased donor pool: 2002 to 2009 University of Liege experience.Outcome of the living kidney donor.Categories of donation after cardiocirculatory death.A more than 20% increase in deceased-donor organ procurement and transplantation activity after the use of donation after circulatory death.Mesenchymal stromal cell therapy in conditions of renal ischaemia/reperfusion.Rationale for the potential use of mesenchymal stromal cells in liver transplantation.Delayed graft function does not harm the future of donation-after-cardiac death in kidney transplantation.Renal transplantation from living related donors: a single center experience in Viet Nam.Infusion of mesenchymal stromal cells after deceased liver transplantation: A phase I-II, open-label, clinical study.Inguinal hernia surgery in developing countries: should laparoscopic repairs be performed ?Administration of mesenchymal stromal cells before renal ischemia/reperfusion attenuates kidney injury and may modulate renal lipid metabolism in ratsOutcome of patients with hepatocellular carcinoma listed for liver transplantation within the Eurotransplant allocation system.Laparoscopic liver resection of benign liver tumors.Liver transplantation for hepatic trauma: Discussion about a case and its management.Does comfort therapy during controlled donation after circulatory death shorten the life of potential donors?Liver transplantation from donation after cardiac death donors: initial Belgian experience 2003-2007.Reversal of oxalosis cardiomyopathy after combined liver and kidney transplantation.Intracellular free iron content of rat liver tissue after cold ischemia.Mycophenolate mofetil monotherapy in stable liver transplant recipients with progressive renal failure.What is the potential increase in the heart graft pool by cardiac donation after circulatory death?Luminal contact with University of Wisconsin solution improves human small bowel preservation.Preface to the 15(th) Annual Meeting of the Belgian Transplantation Society.A modified surgical model of fulminant hepatic failure in the rat.
P50
Q26799905-7DD5043D-D9D1-40C2-9FFD-6CC67C41ADEDQ28373882-0ED3C4DB-4B1E-44E0-A300-389139DB3532Q28475911-1E8A91FD-AB33-40F6-8699-A991CAF6EA06Q33576536-E6E4D992-F62E-4FDD-AA79-41AFF508C418Q34017792-E41A0F9A-27FA-4D36-813B-8C8A75B28BE1Q34099285-DBC98E93-E5E9-47C8-989D-8FD083C185B4Q34876407-961C12BC-B111-47C5-8707-4C65AF8AB4E4Q34970592-D51875ED-C80F-44F3-82B5-782EF559B5DDQ35093659-610288D3-679E-4A26-9EFC-5E4777ADCCD2Q35136842-AE8D240D-5684-43E1-9939-0AEB09D02C48Q35599208-F23FF1D1-A28B-4F12-923B-CED9AEB147E3Q36103694-E96B294F-76CB-4BC5-AAA0-31BE7C9E802FQ36173974-1C8BCC94-FB21-4A7F-83E1-8D2340DB9540Q36705427-224A106D-58CF-4A4A-B3C4-D4714D7A91DBQ36711123-806CF9F4-7862-41AF-B33B-76325A56727EQ37079961-B19872F7-3542-42A6-AD4E-8F85E645412AQ37621668-85F80047-C7CA-4059-A3D5-D1C3220592FFQ37822150-8E45C40B-BE7B-47E0-9178-820D80A54CC3Q37979776-58E17387-9DBB-451A-82FC-1A746395660DQ38015938-74A2B2BF-B0FF-4264-9640-849C79729F97Q38161671-658D6A08-8F80-43EE-BEF4-C558FF94E574Q38187110-92B363D6-F0A7-49BB-9FD9-560409F684A1Q38282065-9812C041-79C8-44D9-8F6F-CCF9B0D61287Q39521230-5C7EEA02-1DCA-4FC3-9EE5-BA1F1F9C0AD5Q39804110-A08FB332-296B-4C92-BA0C-ACC484887FBCQ40298127-2FF01892-F8ED-48DA-8267-5910DCF0F57BQ41023352-12152F7B-535B-47B3-B728-B434F101F4F2Q41447058-63C07006-76F5-4163-BDED-0096C845B21BQ42650687-189AF311-2C20-4E6D-8EF7-3F722FCDBA62Q42684927-795FE895-42EE-4A2A-9CE0-96F626E3553BQ42736157-B8E843E7-461D-4E44-9583-4AB5A9FDCCD8Q43606223-442DEF06-358C-4918-B0B5-46D21DE5C3DFQ43757875-C75445B3-F263-4F0E-BF87-0656FE08F954Q43903527-B269217D-9819-41A9-B2BB-429859265E36Q44008867-1F4892BE-4830-4DB2-B622-6A8958BB46A5Q44008877-8B8FB5AD-7586-4DA2-96B6-A51F05BEFCD8Q44244667-568A0B8B-4DD8-49CF-9785-15BB06F92A96Q44818765-D7FA7B45-DCEC-4317-852A-EC427E51F17AQ44835077-3BD0358B-81C4-4411-867A-CC7D3D31F0AEQ44876814-9B148499-7D0B-450E-AE03-46F60A385988
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Olivier Detry
@ast
Olivier Detry
@en
Olivier Detry
@es
Olivier Detry
@nl
Olivier Detry
@sl
type
label
Olivier Detry
@ast
Olivier Detry
@en
Olivier Detry
@es
Olivier Detry
@nl
Olivier Detry
@sl
prefLabel
Olivier Detry
@ast
Olivier Detry
@en
Olivier Detry
@es
Olivier Detry
@nl
Olivier Detry
@sl
P106
P1153
7006112871
P21
P31
P496
0000-0002-9436-6673